A detailed history of State Board Of Administration Of Florida Retirement System transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, State Board Of Administration Of Florida Retirement System holds 261,575 shares of VRTX stock, worth $118 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares
261,575
Previous 266,540 1.86%
Holding current value
$118 Million
Previous $125 Million 2.62%
% of portfolio
0.24%
Previous 0.25%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$460.0 - $505.78 $2.28 Million - $2.51 Million
-4,965 Reduced 1.86%
261,575 $122 Million
Q2 2024

Aug 08, 2024

SELL
$392.81 - $485.53 $15.5 Million - $19.1 Million
-39,335 Reduced 12.86%
266,540 $125 Million
Q1 2024

May 08, 2024

BUY
$407.69 - $446.08 $7.47 Million - $8.17 Million
18,325 Added 6.37%
305,875 $128 Million
Q4 2023

Feb 09, 2024

SELL
$343.0 - $410.68 $4.07 Million - $4.87 Million
-11,859 Reduced 3.96%
287,550 $117 Million
Q3 2023

Nov 08, 2023

BUY
$338.18 - $362.46 $1.56 Million - $1.67 Million
4,613 Added 1.56%
299,409 $104 Million
Q2 2023

Aug 11, 2023

SELL
$314.42 - $351.91 $3.48 Million - $3.9 Million
-11,079 Reduced 3.62%
294,796 $104 Million
Q1 2023

Jun 14, 2023

SELL
$283.23 - $323.1 $832,696 - $949,914
-2,940 Reduced 0.95%
305,875 $96.4 Million
Q1 2023

May 11, 2023

SELL
$283.23 - $323.1 $832,696 - $949,914
-2,940 Reduced 0.95%
305,875 $96.4 Million
Q4 2022

Jun 14, 2023

BUY
$285.76 - $321.48 $840,134 - $945,151
2,940 Added 0.96%
308,815 $89.2 Million
Q4 2022

Feb 07, 2023

SELL
$285.76 - $321.48 $645,817 - $726,544
-2,260 Reduced 0.73%
308,815 $89.2 Million
Q3 2022

Nov 08, 2022

SELL
$273.83 - $305.53 $1.2 Million - $1.34 Million
-4,400 Reduced 1.39%
311,075 $90.1 Million
Q2 2022

Aug 05, 2022

BUY
$234.96 - $292.55 $254,226 - $316,539
1,082 Added 0.34%
315,475 $88.9 Million
Q1 2022

May 06, 2022

SELL
$221.42 - $260.97 $2.21 Million - $2.6 Million
-9,969 Reduced 3.07%
314,393 $82 Million
Q4 2021

Feb 08, 2022

SELL
$177.01 - $223.45 $427,302 - $539,408
-2,414 Reduced 0.74%
324,362 $71.2 Million
Q3 2021

Nov 08, 2021

SELL
$181.39 - $202.99 $1.43 Million - $1.6 Million
-7,864 Reduced 2.35%
326,776 $59.3 Million
Q2 2021

Aug 10, 2021

BUY
$187.49 - $221.1 $126,368 - $149,021
674 Added 0.2%
334,640 $67.5 Million
Q1 2021

May 10, 2021

SELL
$207.02 - $241.31 $3.14 Million - $3.66 Million
-15,170 Reduced 4.35%
333,966 $71.8 Million
Q4 2020

Feb 08, 2021

SELL
$207.01 - $276.09 $1.18 Million - $1.57 Million
-5,679 Reduced 1.6%
349,136 $82.5 Million
Q3 2020

Nov 09, 2020

BUY
$255.65 - $303.1 $83,597 - $99,113
327 Added 0.09%
354,815 $96.6 Million
Q2 2020

Aug 07, 2020

BUY
$225.48 - $295.8 $1.89 Million - $2.48 Million
8,375 Added 2.42%
354,488 $103 Million
Q1 2020

May 05, 2020

BUY
$199.77 - $247.81 $2.02 Million - $2.51 Million
10,113 Added 3.01%
346,113 $82.4 Million
Q4 2019

Feb 03, 2020

SELL
$166.71 - $223.91 $254,066 - $341,238
-1,524 Reduced 0.45%
336,000 $73.6 Million
Q3 2019

Nov 07, 2019

SELL
$166.23 - $187.09 $87,603 - $98,596
-527 Reduced 0.16%
337,524 $57.2 Million
Q2 2019

Aug 05, 2019

SELL
$164.61 - $190.37 $1.21 Million - $1.41 Million
-7,381 Reduced 2.14%
338,051 $62 Million
Q1 2019

May 03, 2019

BUY
$163.73 - $194.7 $6,549 - $7,788
40 Added 0.01%
345,432 $63.5 Million
Q4 2018

Feb 01, 2019

SELL
$151.91 - $192.21 $566,624 - $716,943
-3,730 Reduced 1.07%
345,392 $57.2 Million
Q3 2018

Oct 31, 2018

SELL
$167.73 - $192.74 $320,867 - $368,711
-1,913 Reduced 0.54%
349,122 $67.3 Million
Q2 2018

Aug 06, 2018

SELL
$145.72 - $169.96 $134,353 - $156,703
-922 Reduced 0.26%
351,035 $59.7 Million
Q1 2018

May 04, 2018

SELL
$151.6 - $177.13 $1.42 Million - $1.66 Million
-9,395 Reduced 2.6%
351,957 $57.4 Million
Q4 2017

Feb 01, 2018

SELL
$137.28 - $155.55 $1 Million - $1.13 Million
-7,293 Reduced 1.98%
361,352 $54.2 Million
Q3 2017

Oct 31, 2017

BUY
$148.13 - $162.24 $54.6 Million - $59.8 Million
368,645
368,645 $56 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $116B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track State Board Of Administration Of Florida Retirement System Portfolio

Follow State Board Of Administration Of Florida Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Board Of Administration Of Florida Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on State Board Of Administration Of Florida Retirement System with notifications on news.